U.S. Earnings Preview: Before Market Open Nov. 11

Dow Jones11-11

This article was automatically generated by Dow Jones using technology from Automated Insights.

The following companies are among those expected to report their latest financial results before the market opens.

ODDITY Tech Ltd.'s third-quarter EPS is forecast at 19 cents. Adjusted EPS is forecast at 30 cents.

InMode Ltd.'s third-quarter EPS is forecast at 28 cents, compared with 34 cents in the prior-year period. Adjusted EPS is forecast at 32 cents.

4D Molecular Therapeutics Inc.'s third-quarter EPS is forecast at a loss of $1.06, compared with a loss of $1.01 in the prior-year period. Adjusted EPS is forecast at a loss of $1.05.

Cadiz Inc.'s third-quarter EPS is forecast at a loss of 14 cents, compared with a loss of 10 cents in the prior-year period. Adjusted EPS is forecast at a loss of 13 cents.

Prelude Therapeutics Inc.'s third-quarter EPS is forecast at 24 cents. Adjusted EPS is forecast at 1 cent.

Fulcrum Therapeutics Inc.'s third-quarter EPS is forecast at a loss of 11 cents, compared with a loss of 31 cents in the prior-year period. Adjusted EPS is forecast at a loss of 4 cents.

Lexeo Therapeutics Inc.'s third-quarter EPS is forecast at a loss of 33 cents, compared with a loss of 33 cents in the prior-year period. Adjusted EPS is forecast at a loss of 32 cents.

Generated from Dow Jones Calendar Live with data from Dow Jones and Factset.

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment